Ferron Pharma of Jakarta is an MHRA- and TGA-certifi ed Farmak International is a Ukrainian company with experience
Indonesian company that provides pharmaceutical services from in all aspects of the manufacturing of nasal/ear/eye drops, sprays,
development to contract manufacturing. Its competencies include vials, ampoules, capsules, tablets in fi nished dosage form and
modifi ed release formulation development, and solid dosage and bulk. It offers full services in contract manufacturing as well as
sterile manufacturing (including lyophilised products). Also based co-marketing, out-licensing, in-licensing and R&D co-operations.
in Jakarta is Novell Pharmaceutical Laboratories, which will
Astron Research is an IP-oriented Indian contract formulation
be present to offer fi nished products and contract manufacturing
research organisation providing such services as formulation
services. Its manufacturing facility is constructed according to
research, dossier sale with supplies, analytical and regulatory
Australian TGA guidelines and is capable of producing tablets,
services. Astron has an MHRA-approved laboratory in the UK, which
capsules, softgel capsules, liquid, and sterile preparations
conducts batch releases, contract analyses and stability studies.
(ampoules or vials).
Kinsy is an independent Spanish company dedicated to the
DBI, of Idron in France, is dedicated to providing a small-scale
custom synthesis of pharmaceutical intermediates and APIs. Its
production site for the various players in the biotechnology
expertise in a wide variety of chemical reactions makes Kinsy an
research arena and pharmaceutical industry seeking pre-
outsourcing partner of choice. It aims for high quality, safety and
commercial (up to 10,000 vials and 20,000 syringes)
environmental standards.
manufacturing of liquid or lyophilised drug products considered
highly active.
In 2009, Novasep’s Le Mans site (specialised in highly potent APIs)
obtained the Safebridge certifi cation, recognising its expertise
Italy’s E-Pharma Trento specialises in the development and
in HPAI process development and contract manufacturing. Since
production of niche delivery forms, such as effervescent, soluble,
the Henogen acquisition, Novasep is now able to provide total
chewable and oro-dispersible tablets. It covers the OTC, Rx,
manufacturing of immuno-conjugates, including monoclonal
generics and branded sectors.
antibodies, toxins, conjugation and downstream processing, from
Indoco Remedies is an Indian contract research and
laboratory to commercial scale.
manufacturing services (CRAMS) player offering services in the
Innov’Orga develops, produces and commercialises its own
areas of formulations and active ingredients. It aims to partner
fl uorinated organic building blocks, and offers specifi c expertise
with companies marketing generics.
and knowledge in organic fl uorine chemistry.
Germany’s NextPharma Technologies provides services
Finland’s Orion develops, manufactures and markets human
from early-phase product development, through to clinical
9
and animal pharmaceuticals, as well as APIs and diagnostic tests
trial packaging (Phases I-III) and high-volume commercial
for global markets. CPhI is an important event in its search for
manufacturing. It describes itself as a leader in lyophilisation,
partners, says VP Hanspeter Ros from Orion’s Fermion subsidiary.
sterile fi ll/fi nish, pellet technologies, specialist product
manufacturing, pre-fi lled syringes, vials and ampoules. The Orofi no Pharmaceuticals Group (Biopharma/Injectalia/
K24 Pharmaceuticals/Achir Pharma) bought the former Knoll
The Swiss contract manufacturer Rohner has created the
and Abbott manufacturing site in Liestal, Switzerland. The new
new position of head of strategic sourcing. Dr Matthias Guex
company, Drug’ON Pharma Switzerland, produces APIs and
will evaluate “make or buy” decisions and enlarge Rohner’s
fi ne chemicals and is starting investments in its new sterile API and
technological portfolio.
biotech API departments.
Solvias has completed its new kg-scale cGMP manufacturing
Italy’s Geymonat specialises in the manufacturing and marketing
plant in Basel, Switzerland. The new facility is to complement
of drugs, principally in gynaecology and phlebology. Gland
the fi rm’s existing laboratory with the rapid and cost-effective
Pharma is an India-based injectables manufacturing company
manufacturing of materials for use in Phase I/IIa clinical studies.
boasting world-class facilities that have been approved by the
Swiss Caps, part of Aenova group, describes itself as a leading
FDA. Gland Pharma has expertise in heparin and LMW heparin
contract manufacturer and service provider for solid dosage forms,
technology. The fi rm offers services in areas such as contract
such as soft capsules, tablets and effervescent tablets.
manufacturing, product development and contract research.
Germany’s WC Heraeus is a specialist in biotechnology, chemical
Cambrex Profarmaco of Milan, Italy has launched R- and
synthesis/analysis, custom manufacturing, regulatory affairs,
S-transaminase enzyme kits to synthesise chiral amines with high
purifi cation and separation techniques, homogeneous catalysts,
chemical and enantiomeric purity from a broad range of ketone
heterogeneous catalysts and the refi ning of spent catalysts.
substrates.
Waxtech Pharma, a South African player, manufactures wax-
based dosage forms for the pharmaceutical industry. Its patented
Excipients and formulations
Waxtab and Microwax products offer advantages including Another large grouping of exhibitors will be suppliers of
extended shelf-life, reduced side-effects and controlled release. pharmaceutical excipients and formulation technologies.
Scrip World Pharmaceutical News Supplement August 2009
cphi.com | icsexpo.com | p-mec.com | bioph-online.com
wherepharmameets.com | scripnews.com
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44